Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2003
03/13/2003US20030049617 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
03/13/2003US20030049609 Viral proteins capable of binding LAR
03/13/2003US20030049606 Novel anti-viral and anti-proliferative agents derived from STAT1 transcription factor
03/13/2003US20030049604 Viral proteins for use in the treatment and prevention of infection and viral diseases
03/13/2003US20030049601 Detecting hepatitis in sample; obtain sample, incubate with binding agent, detect complex, presence of complex indicate hepatitis virus
03/13/2003US20030049600 Kits for use in the detection of virus in sample
03/13/2003US20030049298 Use of microparticles with adsorbed antigen to stimulate immune responses
03/13/2003US20030049279 Polysaccharide encapsualted antigen
03/13/2003US20030049278 Transmission blocking vaccine against malaria
03/13/2003US20030049276 Two-step immunization procedure against the pyramyxoviridae family of viruses using attenuated viral strains and subunit protein preparation
03/13/2003US20030049275 Composition and method for inducing tolerance to viral infection in aquatic animals
03/13/2003US20030049274 PRRSV vaccines
03/13/2003US20030049271 Diagnosis, therapy of bacteria infections
03/13/2003US20030049269 Mycobacterium tuberculosis DNA sequences encoding immunostimulatory peptides and methods for using same
03/13/2003US20030049268 Novel composition
03/13/2003US20030049267 Systemic immune response induced by mucosal administration of lipid-tailed polypeptides without adjuvant
03/13/2003US20030049266 Induce immunology response usin gpolynucleotide
03/13/2003US20030049265 Heliobacter pylori antigen
03/13/2003US20030049264 Releasing neurotransmitters; analgesics
03/13/2003US20030049263 Vaccine; nucleotide sequences
03/13/2003US20030049262 Methods for identification, diagnosis, and treatment of breast cancer
03/13/2003US20030049260 Method of improving cognitive function
03/13/2003US20030049259 Control of lymphocyte localization by LEEP-CAM activity
03/13/2003US20030049258 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/13/2003US20030049253 Polymeric conjugates for delivery of MHC-recognized epitopes via peptide vaccines
03/13/2003US20030049252 Controlling immunology response; autoimmune disease, antiallergens
03/13/2003US20030049237 Isolated nucleic acids; prevent binding of antigens; peanut allergies
03/13/2003US20030049235 Veto cells effective in preventing graft rejection and devoid of graft versus host potential
03/13/2003US20030049229 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
03/13/2003US20030049227 Antitumor, anticarcinogenic agents; using fusion protein
03/13/2003US20030049211 Remedies and preventives for dental diseases
03/13/2003US20030049203 Targeted nucleic acid constructs and uses related thereto
03/13/2003DE3890874C2 Rekombinante Viren Recombinant viruses
03/13/2003CA2477811A1 Chicken anemia virus vaccine from cell line
03/13/2003CA2471735A1 Desensitizers
03/13/2003CA2459816A1 Hybrid and tandem expression of neisserial proteins
03/13/2003CA2459348A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003CA2459138A1 Modified human growth hormone
03/13/2003CA2459136A1 A caspase-8 binding protein, its preparation and use
03/13/2003CA2459077A1 Diagnosis of carcinomas
03/13/2003CA2458995A1 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003CA2458993A1 A method for the treatment or prevention of bone erosion
03/13/2003CA2458985A1 Antibodies against caspase-8, their preparation and use
03/13/2003CA2458915A1 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer
03/13/2003CA2458883A1 Methods of treating mycocardial event related conditions with thymosin beta 4
03/13/2003CA2458799A1 Treatment for central nervous system disorders
03/13/2003CA2458780A1 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2458538A1 Antigen mimotopes and vaccine against cancerous diseases
03/13/2003CA2458237A1 Vaccine therapies and prophylactic treatments of atherosclerotic diseases
03/13/2003CA2457541A1 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
03/13/2003CA2457520A1 Modified transferrin fusion proteins
03/12/2003EP1291434A2 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease
03/12/2003EP1291424A1 Gasc1 gene
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1290230A2 Hepatitis c virus conjugates
03/12/2003EP1290205A2 Duplexed parvovirus vectors
03/12/2003EP1290179A2 Method for isolating and using fungal hemolysin
03/12/2003EP1290177A1 Bartonella henselae virb operon and proteins encoded thereby
03/12/2003EP1290171A2 Compositions and methods for the therapy and diagnosis of lung cancer
03/12/2003EP1290166A1 Mutation in the beta 2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
03/12/2003EP1290154A2 The identification and use of effectors and allosteric molecules for the alteration of gene expression
03/12/2003EP1290148A2 AMINOACYL tRNA SYNTHETASES
03/12/2003EP1290140A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof
03/12/2003EP1290137A2 Virulence genes, proteins, and their use
03/12/2003EP1290033A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
03/12/2003EP1290029A2 Compositions comprising net-4 modulators and their use for treating neoplastic disease
03/12/2003EP1290027A2 Immunoadhesin for the prevention of rhinovirus infection
03/12/2003EP1290023A2 Nuclear factor kb inducing factor
03/12/2003EP1290021A2 Polynucleotide sequence encoding a putative cell adhesion molecule
03/12/2003EP1290019A2 Use of coiled-coil structural scaffold to generate structure-specific peptides
03/12/2003EP1290016A2 Vaccine for congenital tremors in pigs
03/12/2003EP1290015A2 Epididymis-specific proteins with fibronectin type ii modules
03/12/2003EP1290005A2 Vegf-modulated genes and methods employing them
03/12/2003EP1289570A1 Liposomal encapsulation of chelated actinium-225 and uses thereof
03/12/2003EP1289564A2 T cell receptor fusions and conjugates and methods of use thereof
03/12/2003EP1289555A2 Method to induce the th1 immune response
03/12/2003EP1289553A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
03/12/2003EP1289552A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
03/12/2003EP1289551A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
03/12/2003EP1289550A1 Chlamydial glycolipid vaccines
03/12/2003EP1289549A2 The use of plant oil-bodies in vaccine delivery systems
03/12/2003EP1289547A2 Immunization through oral administration of a vaccine with an edible product
03/12/2003EP1289546A1 Combined preparation for the treatment of neoplasic diseases
03/12/2003EP1289545A1 Snthetic vaccine for tick control
03/12/2003EP1289494A2 Powder compositions
03/12/2003EP0831881B1 Cetp for increasing hdl cholesterol level
03/12/2003EP0811067B1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test
03/12/2003EP0705339B1 Human cell adhesion protein aamp-1 and uses thereof
03/12/2003EP0274482B2 Isolated dna sequences associated with multidrug resistance in human cells
03/12/2003CN1402797A Compositions and methods for preventing transepithelial transmission of HIV
03/12/2003CN1402792A Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
03/12/2003CN1402788A 纤维蛋白溶解活性多肽 Polypeptide fibrinolytic activity
03/12/2003CN1402785A Novel compounds
03/12/2003CN1402782A MAGE-A12 antigenic peptides and uses thereof
03/12/2003CN1402780A 感染性克隆 Infectious clone
03/12/2003CN1402702A Beta 2-adrenergic receptor agonists
03/12/2003CN1401787A Process for preparing polyglycocaester monoclonal antibody
03/12/2003CN1401776A Construction and expression of recombinant human B cell stimulating factor (rhBLyS) expression vector, and monoclonal antibody preparation and use
03/12/2003CN1401768A Horse infectious anemia donkey embryo skin cell weak-toxic vaccine strain and culture method thereof
03/12/2003CN1401390A Immunoregulation medicine-antibody poietins, preparing process and use thereof
1 ... 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 ... 1823